Vir Biotechnology (VIR) Current Assets (2018 - 2026)
Vir Biotechnology's Current Assets was $573.74 million in Q2 2026, down 22.0% from $735.71 million a year earlier but up 9.7% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Vir Biotechnology came in at $514.08 million, down 50.7% from FY2024.
- Current Assets has now declined for three consecutive years, with a five-year compound annual growth rate of -7.8% (FY2020 to FY2025).
- In earlier years, Current Assets was $1.04 billion in FY2024 (-34.4%), $1.59 billion in FY2023 (-37.0%), $2.52 billion in FY2022 (+61.2%) and $1.56 billion in FY2021 (+102.3%).
- Quarterly Current Assets has moved between $514.08 million (Q4 2025) and $2.57 billion (Q1 2022) over five years.
- Compared with a year earlier, Current Assets has declined for 14 straight quarters, with an average decline of 37.7% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q2 2022 (growth of 165.4%); the worst was Q4 2025 (a decline of 50.7%).
- Per Business Quant data, VIR's Current Assets in the three quarters before Q2 2026 was $522.99 million (Q1 2026), $514.08 million (Q4 2025) and $545.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Vir Biotechnology | 1.78 Bn | 1.78 Bn | 238.95 Mn | 573.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 573.74 Mn |
| Mar 31, 2026 | 522.99 Mn |
| Dec 31, 2025 | 514.08 Mn |
| Sep 30, 2025 | 545.68 Mn |
| Jun 30, 2025 | 735.71 Mn |
| Mar 31, 2025 | 932.21 Mn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.77 Bn |
| Jun 30, 2023 | 1.95 Bn |
| Mar 31, 2023 | 2.36 Bn |
| Dec 31, 2022 | 2.52 Bn |
| Sep 30, 2022 | 2.41 Bn |
| Jun 30, 2022 | 2.29 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 1.56 Bn |
| Sep 30, 2021 | 1.07 Bn |
API Access
Vir Biotechnology Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();